Login

Reflecting on My Failure to Make Gumroad a Billion Dollar Company|Sahil Lavingia,Founder,SHL Capital 00:10:00

Share On Facebook Share On Twitter

Founder and CEO of Gumroad. Previously, he was early at Pinterest.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Supports founders with early-stage and seed VC funding, investing in their professional & personal growth|Russ Wilcox,Partner,Pillar VC
00:10:00
Analyzing Market Opportunities: Insights into the Foord Equity Fund | Cobie Legrange - Fundamental Analyst, Acsis
00:10:00
Shifting Market Dynamics: Evaluating Risk and Opportunity | Sébastien Page, CIO , T. Rowe Price.
00:10:00
Retirement Revealed: Insights from Barry LaValley | Matthew Kelley - President of Gold Medal Waters, Inc.
00:10:00
True North Copper Begins Mining at Wallace North Deposit in Queensland
00:10:00
Tax Reform: Effective Strategies with eMoney and Holistiplan - David Wise | Hilltop Wealth Advisors
00:10:00
"Rebounding and Reinventing: Winnie Chiu on Leading Dorsett Hospitality through Unprecedented Times"
00:10:00
Navigating the Cannabis Industry: Insights from Ron Throgmorton, CEO of Diego Pellicer
00:10:00
Oscar Oberg: Navigating the Future of Small and Micro-Cap Investments
00:10:00
Axiom Exploration Group: Cutting Costs and Maximizing Results with Advanced Survey Technology
00:10:00
Vetrya Spa CEO Luca Tomassini Speaks at Glocal Economic Forum ESG89 | Luca Tomassini, Ceo of Vetrya Spa
00:10:00
Stephen Siderow, co-founder of BlueMountain Capital Management LLC, discusses his investment strategy focused on risk management and diversified portfolios.|Andrew Todd Feldstein is the Blue Mountain Capital Management's CEO

© 2026 Nehu